Menu

Axsome Therapeutics, Inc. (AXSM) Q3 2026 Earnings Call Transcript
📰

Axsome Therapeutics, Inc. (AXSM) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·14 days ago
#iHiwmT6Y
#seekingalpha#research#call#chief#securities
Reading 0:00
15s threshold

Axsome Therapeutics, Inc. ( AXSM ) Q3 2026 Earnings Call November 2, 2026 8:00 AM EST

Company Participants

Ashley Dong

Herriot Tabuteau - Founder, Chairman, CEO & President

Nick Pizzie - Chief Financial Officer

Ari Maizel - Chief Commercial Officer

Mark Jacobson - Chief Operating Officer

Conference Call Participants

Srikripa Devarakonda - Truist Securities, Inc., Research Division

Guofang Li - Wolfe Research, LLC

Ashwani Verma - UBS Investment Bank, Research Division

Leonid Timashev - RBC Capital Markets, Research Division

Marc Goodman - Leerink Partners LLC, Research Division

Jason Gerberry - BofA Securities, Research Division

David Amsellem - Piper Sandler & Co., Research Division

Sean Laaman - Morgan Stanley, Research Division

Malcolm Hoffman - BMO Capital Markets Equity Research

Lin Tsai - Jefferies LLC, Research Division

Joseph Thome - TD Cowen, Research Division

Yatin Suneja - Guggenheim Securities, LLC, Research Division

Benjamin Burnett - Wells Fargo Securities, LLC, Research…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.